Adrian Rendon

Adrian Rendon

Universidad Autónoma de Nuevo León

H-index: 38

Latin America-Mexico

About Adrian Rendon

Adrian Rendon, With an exceptional h-index of 38 and a recent h-index of 27 (since 2020), a distinguished researcher at Universidad Autónoma de Nuevo León, specializes in the field of NEUMOLOGIA, TUBERCULOSIS, COCCIDIOIDOMICOSIS EPOC ASMA.

His recent articles reflect a diverse array of research interests and contributions to the field:

Diagnosis of tuberculosis: a historical challenge

El diagnóstico de la tuberculosis: un desafío histórico

Understanding the Burden of Respiratory Syncytial Virus in Older Adults in Latin America: An Expert Perspective on Knowledge Gaps

Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendations

Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers

Comparison of CD4+/CD8+ Lymphocytic Subpopulations Pre-and Post-Antituberculosis Treatment in Patients with Diabetes and Tuberculosis

Prevalence of Latent TB Infection in Patients With Metabolic Syndrome

Cluster analyses from the real-world NOVELTY study: six clusters across the asthma-COPD spectrum

Adrian Rendon Information

University

Universidad Autónoma de Nuevo León

Position

Profesor Facultad de Medicina de la

Citations(all)

4788

Citations(since 2020)

2766

Cited By

2890

hIndex(all)

38

hIndex(since 2020)

27

i10Index(all)

67

i10Index(since 2020)

59

Email

University Profile Page

Universidad Autónoma de Nuevo León

Adrian Rendon Skills & Research Interests

NEUMOLOGIA

TUBERCULOSIS

COCCIDIOIDOMICOSIS EPOC ASMA

Top articles of Adrian Rendon

Title

Journal

Author(s)

Publication Date

Diagnosis of tuberculosis: a historical challenge

NCT Neumología y Cirugía de Tórax

Adrian Rendon

Berenice Soto-Moncivais

Brenda Nohemí Lozano-Rodríguez

2024/3/5

El diagnóstico de la tuberculosis: un desafío histórico

NCT Neumología y Cirugía de Tórax

Adrian Rendon

Berenice Soto-Moncivais

Brenda Nohemí Lozano-Rodríguez

2024/3/5

Understanding the Burden of Respiratory Syncytial Virus in Older Adults in Latin America: An Expert Perspective on Knowledge Gaps

Ricardo Amorim Correa

Francisco Arancibia

Renato De Ávila Kfouri

Alberto Chebabo

Gabriel García

...

2024/2/15

Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendations

Peter Kardos

Jaime Correia de Sousa

Ulrich Heininger

Andreas Konstantopoulos

C Raina MacIntyre

...

2024/12/31

Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers

The Journal of Allergy and Clinical Immunology: In Practice

Bo Ding

Stephanie Chen

Eleni Rapsomaniki

Anna Quinton

William Cook

...

2024/4/1

Comparison of CD4+/CD8+ Lymphocytic Subpopulations Pre-and Post-Antituberculosis Treatment in Patients with Diabetes and Tuberculosis

Pathogens

Erick J Rendón Ramírez

Adrián G Rosas-Taraco

Berenice Soto-Monciváis

Perla R Colunga-Pedraza

Rosario Salazar-Riojas

...

2023/9/20

Prevalence of Latent TB Infection in Patients With Metabolic Syndrome

B Soto-Moncivais

A Gonzalez Gutierrez

A Rendon

RM Medina Jimenez

BN Lozano Rodriguez

...

2023/5

Cluster analyses from the real-world NOVELTY study: six clusters across the asthma-COPD spectrum

The Journal of Allergy and Clinical Immunology: In Practice

Rod Hughes

Eleni Rapsomaniki

Aruna T Bansal

Jørgen Vestbo

David Price

...

2023/9/1

Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD

Respiratory research

Erin L Tomaszewski

Mark J Atkinson

Christer Janson

Niklas Karlsson

Barry Make

...

2023/4/8

Impact of COVID-19 on diagnosis of TB, MDR-TB and on mortality in 11 countries in Europe, Northern America and Australia. A Global Tuberculosis Network study.

International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases

Joanitah Nalunjogi

S Mucching-Toscano

JP Sibomana

R Centis

L D'Ambrosio

...

2023/3/7

Clinical standards for the management of adverse effects during treatment for TB

The International Journal of Tuberculosis and Lung Disease

KP Singh

ACC Carvalho

R Centis

GB Migliori

SG Mpagama

...

2023/7/1

Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort

European Respiratory Journal

Global Tuberculosis Network

Nicolas Casco

Alberto Levi Jorge

Domingo Juan Palmero

Jan-Willem Alffenaar

...

2023/11/1

Symptom burden, health status, and productivity in patients with uncontrolled and controlled severe asthma in novelty

Journal of Asthma and Allergy

Bo Ding

Stephanie Chen

Divyansh Srivastava

Anna Quinton

William Cook

...

2023/12/31

DFV890: a new oral NLRP3 inhibitor—tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function

Infection

Ildiko Madurka

Alexander Vishnevsky

Joan B Soriano

Stephanus J Gans

Danilo Joel Salazar Ore

...

2023/6

Correction to: DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach

Advances in Therapy

Dave Singh

Diego Litewka

Rafael Páramo

Adrian Rendon

Abdullah Sayiner

...

2023

Delaying disease progression in COPD with early initiation of dual bronchodilator or triple inhaled pharmacotherapy (DEPICT): a predictive modelling approach

Advances in Therapy

Dave Singh

Diego Litewka

Rafael Páramo

Adrian Rendon

Abdullah Sayiner

...

2023/10

Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global …

International Journal of Infectious Diseases

Joanitah Nalunjogi

Sergio Mucching-Toscano

Jean Pierre Sibomana

Rosella Centis

Lia D'Ambrosio

...

2023/5/1

Publication of results from DFV890D12201 study: DFV890, a new oral NLRP3 inhibitor, tested for the treatment of SARS-CoV-2 infected patients with COVID-19 pneumonia and …

DFV890, a new oral NLRP3 inhibitor, tested for the treatment of SARS-CoV-2 infected patients with COVID-19 pneumonia and impaired respiratory function: Results from a randomised Phase 2 trial

Guido Junge

Beata Mehes

Karin Meiser

Ewa Gatlik

Ulrike Sommer

...

2022

Medidas de confinamento específicas de cada país em resposta à pandemia de COVID-19 e seu impacto no controle da tuberculose: um estudo global

Jornal Brasileiro de Pneumologia

Giovanni Battista Migliori

Pei Min Thong

Jan-Willem Alffenaar

Justin Denholm

Marina Tadolini

...

2022/4/20

Comparison of QuantiFERON-TB Gold Plus vs tuberculin skin test in a healthy population in Mexico

A Rendón

AG Rosas Taraco

JM Llaca Díaz

B Soto Monciváis

A Gonzalez Gutierrez

...

2022/9/4

See List of Professors in Adrian Rendon University(Universidad Autónoma de Nuevo León)

Adrian Rendon FAQs

What is Adrian Rendon's h-index at Universidad Autónoma de Nuevo León?

The h-index of Adrian Rendon has been 27 since 2020 and 38 in total.

What are Adrian Rendon's top articles?

The articles with the titles of

Diagnosis of tuberculosis: a historical challenge

El diagnóstico de la tuberculosis: un desafío histórico

Understanding the Burden of Respiratory Syncytial Virus in Older Adults in Latin America: An Expert Perspective on Knowledge Gaps

Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendations

Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers

Comparison of CD4+/CD8+ Lymphocytic Subpopulations Pre-and Post-Antituberculosis Treatment in Patients with Diabetes and Tuberculosis

Prevalence of Latent TB Infection in Patients With Metabolic Syndrome

Cluster analyses from the real-world NOVELTY study: six clusters across the asthma-COPD spectrum

...

are the top articles of Adrian Rendon at Universidad Autónoma de Nuevo León.

What are Adrian Rendon's research interests?

The research interests of Adrian Rendon are: NEUMOLOGIA, TUBERCULOSIS, COCCIDIOIDOMICOSIS EPOC ASMA

What is Adrian Rendon's total number of citations?

Adrian Rendon has 4,788 citations in total.